The genomics medicine revolution brings new hope in the fight against cancer. Thousands of tumours from different cancer types have been sequenced and the genomes characterised, confirming the complexity of cancer genomes and providing a new perspective in tackling cancer. Computational approaches have the ability to decipher cancer genome marks, but still there are many challenges to be faced prior to translating cancer genome discoveries into clinical medicine.
The Translational Bioinformatics Unit uses computational methodologies to achieve genome analyses of cancer patients’ data, in order to identify new biomarkers and mechanisms of drug response. Our main goal is to translate this knowledge into effective treatments for cancer patients.